# data[].attributes.body
In 1956 one of the first heart-lung machines was developed by Doctor  Willem Johan "Pim" Kolff

1957: Concept of the artificial heart is brought to reality by  Dr. Kolff and Dr. Tetsuzo Akutsu  at the Cleveland Clinic

1969: The first artificial heart transplant is implanted into a human by heart surgeon  Dr. Denton Cooley.

2002:  The CardioWest's temporary total artificial heart pivotal clinical study is finally completed.

2004: The artifical heart is given the name  SynCardia temporary CardioWest™ Total Artificial Heart.

2010: first U.S total artificial heart patient is discharged from hospital with the freedom portable driver.

# data[].attributes.headline
Current Technology for Artificial Hearts

# data[].attributes.subject
Current Technology for Artificial Hearts

# data[].attributes.body
The most recent Total artificial heart is the BiVACOR. The  BiVACOR has centrifugal pumps that can provide high flows over 12lpm for dynamic activity. This device has anticipated the life of a human up to 10 years or more. The device is small enough for a child,  and has a small external controller with batteries to allow freedom to the patient.

# data[].attributes.body
AbioCor TAH:

approximately $89,000- $118,000

CardioWest TAH:

approximatley $150,000

# data[].attributes.body
-AbioCor TAH:

Patient must be less than 75  years old

not a transplant candidate during the time of assessment

Multiple inotropic support is required

patient is in bi-ventricular failure that is not treatable by LVAD destination therapy

- CardioWest TAH:

patients who  are in risk of death from a non-reversible bi-ventricular failure

# data[].attributes.body
- AbioCor TAH: Patients with other irreversible end organ functions, inadequate psychosocial support, if noninvasive anatomical assessment reveals improper fi.

- CardioWest TAH: it is contradicted for patients with a body surface areas less than  1.7m².